UCL European Research and Innovation Office

HR Excellence in Research:

UCL has been successful in gaining the European Commission’s HR Excellence in Research Award. The award recognises the systems and practices we have in place to support researchers’ career and professional development in line with the national Research Concordat.

HR Excellence in Research

Horizon 2020 Calls for Proposals:

To view all of the available Horizon 2020 funding, please proceed to the European Union Research Participant Portal.


Call for proposals for ERC Proof of Concept Grant

Aug 01, 2016 22:00PM

Identifier: ERC-2017-PoC
Pillar: Excellent Science
Planned Opening Date:
Deadline: Thu, 19 Jan 2017 17:00:00 (Brussels local time)


Call for proposals for ERC Starting Grant

Jul 25, 2016 22:00PM

Identifier: ERC-2017-STG
Pillar: Excellent Science
Opening Date:
Deadline: Tue, 18 Oct 2016 17:00:00 (Brussels local time)


Horizon Prize – Low Carbon Energy Inducement Prizes 2016 - CO2 REUSE

Jul 04, 2016 22:00PM

Identifier: H2020-LCE-Prizes-2016-03
Pillar: Societal Challenges
Opening Date:
Deadline: Wed, 3 Apr 2019 17:00:00 (Brussels local time)


Horizon Prize – Low Carbon Energy Inducement Prizes 2016 - PHOTOVOLTAICS MEETS HISTORY

Jul 04, 2016 22:00PM

Identifier: H2020-LCE-Prizes-2016-02
Pillar: Societal Challenges
Opening Date:
Deadline: Wed, 26 Sep 2018 17:00:00 (Brussels local time)


Horizon Prize – Low Carbon Energy Inducement Prizes 2016 - Low Carbon Hospital

Jul 04, 2016 22:00PM

Identifier: H2020-LCE-Prizes-2016-01
Pillar: Societal Challenges
Opening Date:
Deadline: Wed, 3 Apr 2019 17:00:00 (Brussels local time)



Jun 29, 2016 22:00PM

Identifier: COS-SPOC-2016-02-03
Pillar: Improving access to markets
Opening Date:
Deadline: Thu, 8 Sep 2016 17:00:00 (Brussels local time)


SESAR 2020 RPAS Exploratory Research call

Jun 27, 2016 22:00PM

Identifier: H2020-SESAR-2016-1
Pillar: Societal Challenges
Opening Date:
Deadline: Tue, 25 Oct 2016 17:00:00 (Brussels local time)


Project Management

UCL Portico

Depending on the overall requirements and the available Management budget, ERIO is able to offer a range of advice, support and project management services from the negotiation stages until a project's closure, including:

  • Negotiation and administration of the Grant Agreement
  • Drafting, negotiation and administration of the Consortium Agreement 
  • Project monitoring and reporting throughout the project's life cycle
  • Facilitation of communications, including the setup and maintenance of collaboration software, project websites and the organisation of project meetings and reviews
  • Management of Intellectual Property and confidentiality considerations
  • Contractual management, including the maintenance of the various agreements and the drafting of sub-contracts and competitive calls

Following discussions with the European Commission and a successful pilot, ERIO may also (in some cases and where appropriate) be in a position to offer management support and consultancy services to EU funded projects in which UCL is not the project's Coordinator.

This work can be costed into your project's Management budget category, and by bringing ERIO (via UCL) into your project as a managing partner a considerable portion of the administrative burden of EU project management can be removed from the coordinating scientists.

For further details please contact Michael Browne, Head of European Research and Innovation. Tel: +44 (0)20 3108 3120 Email: michael.browne@ucl.ac.uk

Current Projects

Below is a small selection of the projects currently being managed by the European Research and Innovation Office's European Project Managers.


  • Title: "Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease"
  • Call: PHC-13-2014 (New therapies for chronic non-communicable diseases)
  • PI and Coordinator: Prof Rajiv Jalan, Institute of Liver and Digestive Health
  • Total Budget: € 5,913,079.75
  • Duration: 54 months from 30/04/2015
  • Oveview: Chronic liver disease affects about 29-million Europeans accounting for about 170,000 deaths at a cost of around €15.8bn. The three main causes of the disease; alcohol, fatty liver and viral hepatitis are amenable to prevention and treatment. Gut-derived endotoxins and bacterial translocation are central factors implicated in the pathogenesis of fatty liver disease, and, the development and progression of cirrhosis. Treatment of fatty liver and modulation of bacterial translocation in early cirrhosis to prevent complications is an unmet need. Our academic-industrial consortium has developed a novel, patented, safe and cheap nanoporous carbon that modulates the effects of bacterial translocation in animal models of liver disease. We propose to investigate the safety and efficacy of this novel nanoporous carbon in patients with fatty liver disease and cirrhosis. Exploitation of the results of the CARBALIVE project will support the continued development of this carbon through additional private and public sector investment. The use of this innovative therapy is expected to reduce the economic burden of the disease in Europe, allow patients to achieve enhanced quality of life, improve survival, and allow many patients to return to economic productivity.


  • Title: "Fiber-wireless Integrated Networks for 5th Generation Delivery"
  • Call: MSCA-ITN-2014-ETN (Marie Skłodowska-Curie Innovative Training Networks)
  • Coordinator: Dr. John Mitchell, UCL Engineering
  • Total Budget: € 3,867,896.88
  • Duration: 48 months from 01/01/2015
  • Oveview: The FiWiN5G European Training Network aims to produce the next generation of early stage researchers who will be enable Europe to take a leading role in the development of future devices, systems and networks supporting the 5G high-speed wireless internet. To do this, a large number of technologies and devices will need to converge, co-exist and interoperate, and most importantly, cooperate, if this vision is to be realised. A key area within this next generation jigsaw is the integration of optical fibre and radio technologies to enable scalable and manageable networks without a highly complex interface structure and multiple overlaid protocols. FiWiN5G aims to provide doctoral students with the exposure to the range of skills, necessary to address these challenging demands, deep technical knowledge but also key transferable skills common in entrepreneurship, management, financing as well as communication, and societal outreach, all in the context of an industrially supported research programme.


  • Title: "SupramolecularlY eNgineered arCHitectures for optoelectRonics and photONICS: a multi-site initial training action"
  • Call: MSCA-ITN-2014-ETN (Marie Skłodowska-Curie Innovative Training Networks)
  • PI and Coordinator: Prof. Franco Cacialli, Department of Physics and Astronomy
  • Total Budget: € 3,650,589.00
  • Duration: 48 months from 01/01/2015
  • Oveview: Photonics will play a major role in the future of ICT and healthcare and will heavily rely on novel and more performing materials. To lead this “photonics revolution”, the EC needs a highly-skilled scientific and technical workforce that can effectively implement the transition to a truly “knowledge-based society”. SYNCHRONICS mission is to address both needs by training a pool of future science-leaders in the synthesis, characterisation and application to photonics of supramolecularly-engineered functional materials within state-of-art photonic nanostructures fabricated thanks to the top-quality facilities and unique expertise available within the network. This kind of research requires an inter-multidisciplinary, intersectorial approach by specialized and skilled scientists from different disciplines: organic and supramolecular synthesis, theory, surface studies, photophysics, device fabrication and characterisation. The SYNCHRONICS Network, through the integration of these highly specialised and internationally-leading institutions, consolidates the European training efforts in the emerging area of both supramolecular nanoscience and nanophotonics. SYNCHRONICS will deliver 540 person-months of multidisciplinary and intersectorial training that is carefully structured through local, network-wide and extra-network training in both scientific-technical topics, as well as complementary and managerial skills.


  • Title: "Female cancer prediction using cervical omics to individualise screening and prevention"
  • Call: PHC-05-2014
  • PI and Coordinator: Professor Martin Widschwendter, Department of Women’s Cancer
  • Total Budget: € 7,994,746.25
  • Duration: 48 months from 01/09/2015
  • Overview: While prevention of most female specific cancers (ovarian, breast, endometrial) has not progressed substantially in recent years, significant progress has been made with cervical cancer due to accessibility of the cell of origin (cervical smear) and availability of a test for the causal agent (human papilloma virus); together these enable identification of high risk individuals and interventions to prevent infection or halt progression to invasive cancer. Our consortium has developed an exciting opportunity to utilise clinically abundant cervical cells in tandem with a multi-omics enabled (genome, epigenome, metagenome) analysis pipeline to understand an individual’s risk of developing a female specific (gynaecological and breast) cancer and to direct a personalised screening and prevention strategy. Cervical cells –currently collected within cervical cancer screening – provide an ideal window into other female specific cancers because they are (i) an excellent non-invasive source of high quality DNA, (ii) provide a readout for environmental exposure, (iii) are part of the Müllerian tract and (iv) are hormone sensitive, recording (via the epigenome) various hormonal conditions over a lifetime that trigger cancer development. We will examine the effectiveness of the proposed cervical cell omics analysis method and investigate the legal, social, ethical and behavioural issues related to implementation of the risk prediction tool, through direct interaction with stakeholder groups, to ensure its rapid translation into clinical practice across Europe.


  • Title: "European network of HIV/AIDS cohort studies to coordinate at European and International level clinical research on HIV/AIDS"
  • Call: FP7 Health 2010 (Network of Excellence)
  • Coordinator: Dr. Kholoud Porter, Medical Research Council

  • Total Budget: €15.97 million (UCL EC contribution: €2.17 million)
  • Duration: January 2011 to December 2015
  • Oveview: Over the past 15 years, EU-funded cohorts and collaborations (EuroSIDA, CASCADE, COHERE and PENTA) have played a central role in developing our understanding of HIV progression and the effects of ART, enabling European expertise to contribute directly to the advances in patient diagnosis and management worldwide, and providing a continued surveillance mechanism for detection of emerging problems at a European level. Together, these collaborations form the foundation of a Network of Excellence named EuroCoord. EuroCoord currently has access to data from over 250,000 HIV-infected individuals across the European continent and beyond, will address key areas of HIV research aimed at improving the management and life of HIV-infected individuals, whilst exploring differences within sub-groups.
UCL Success